MPW Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -3.16%, SMA50 -4.12%, SMA200 3.4%). The stock’s 14-day RSI is 42.31 (neutral), while the ATR of 0.15 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -20.82% below its high and over 27.09% above its low.

The latest quarter delivered EPS of -$0.03. The next quarter is forecast at $0.01. Next year's EPS is expected at $125.24. Analyst sentiment is bearish. Analyst rating data shows there are 1 Strong Buy ratings, 0 Buy ratings, 2 Hold ratings, 0 Sell rating and 3 Strong Sell ratings. Price targets range from $9.00 to $4.50. The high target offers 67.91% upside. The low target suggests -16.04% downside. The mean target is $5.50. This offers 2.61% upside. Medical Properties Trust, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended October 30, 2025, missed forecasts by -117.11%. The prior quarter beat by -6.67%. Over the last six quarters, Apple has recorded several small beats. These include -370.0% in August 08, 2024.

Medical Properties Trust, Inc. last paid a dividend of 0.33 per share, this equals a trailing yield of roughly 15.71%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.69. This means the shares are trading above this model’s fair value.

Medical Properties Trust, Inc. (NYSE:MPW) closed at $5.36 USD, gaining $0.08 (1.52%) from the previous close of $5.28. The stock is currently mid-range between its 52-week high and low $3.95 and $6.34. With a market capitalization of about $3.22 billion, Medical Properties Trust, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.46). Key stats such as the average daily volume over the past year has been around 7.13 million shares, volume is running light vs its 52-week average. Headquartered in Birmingham, AL, Medical Properties Trust, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Edward K. Aldag Jr., the company employs approximately 118 people and listed since July 08, 2005. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.

Medical Properties Trust, Inc. has 601.10 million shares outstanding. The public float is 493.45 million shares, elevated short interest at 41.54% of float. This equals 173.77 million shares. The short ratio is 17.9 days. Institutional investors hold 72.0% of the float. Insiders own 17.3%. Aldag Edward K JR holds 3.50 million shares, HAMNER R STEVEN has 1.96 million shares and McLean Emmett E has 1.28 million shares. Over the past six months, insider transactions show net selling. They sold 61.00 thousand shares across 2 transactions.

Medical Properties Trust, Inc. trades at a P/E ratio of -16.21, slightly below the S&P 500 average, with a price-to-sales ratio of 3.32 and a price-to-book ratio of 0.7 suggesting the stock is closer to book value. The P/FCF stands at 0.0, also above market averages.

Our AI price prediction model suggests that Medical Properties Trust, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.99%, with price expected at $4.87 by February 16, 2026, within a range of $4.72 to $5.02 3-Month Outlook: Projected rise of 51.0%, reaching $7.58 by May 01, 2026, with a range of $7.36 to $7.80. 1-Year Outlook: Projected gain of 203.59%, with price at $15.24 by February 02, 2027, within a range of $0.00 to $26.66.

Medical Properties Trust, Inc. (NYSE:MPW) shares are flat 2.8% year-to-date currently trading near 52-week highs band. Short-term momentum has been flat over the last quarter, despite recent volatility. Valuation shows Medical Properties Trust, Inc. trading at a premium to the broader market with a P/E of -16.21. Analyst sentiment is cautious, with the majority of ratings in Underweight territory and a mean price target of $12.70, suggesting 152.99% upside. Our AI forecast model points to short-term weakness (-2.99% over two weeks), a medium-term rise (51.0% over three months), and a longer-term gain (203.59% over one year), with expected trading ranges indicating moderate volatility.